Abstract
The toxicity of a short-term exposure totert-butylhydroperoxide in U937 cells was markedly reduced by chemically or experimentally induced respiratory deficiency. Rotenone mitigated the lethal effects of the hydroperoxide over the same concentration-range in which the complex I inhibitor inhibited oxygen utilization. U937 cells that were made respiration deficient by growing them in the presence of either chloramphenicol or ethidium bromide, were in both circumstances highly resistant totert-butylhydroperoxide. The improved survival was not a direct consequence of the absence of electron transport, but rather was attributable to the large amounts of NADH which accumulate in the mitochondria of chemically hypoxic or respiration-deficient cells. Indeed, the toxicity elicited by tert-butylhydroperoxide was also abolished by supplementation with either of two different NADH-linked substrates, namely pyruvate or β-hydroxybutyrate. Accumulation of intramitochondrial NADH, and the resulting cytoprotective effects, was associated with prevention of the loss of nonprotein sulphydryls and mitochondrial membrane potential. Neither rotenone nor pyruvate reduced the toxicity oftert-butylhydroperoxide in thiol-depleted cells. Taken together, these results indicate that depletion of mitochondrial NADH is a critical event in the cytotoxic response totert-butylhydroperoxide since this pyridine nucleotide prevents mitochondrial dysfunction and cell death caused by the hydroperoxide. As a consequence, in hydroperoxide-treated cells electron transport is highly detrimental since it consumes mitochondrial NADH.
Footnotes
-
Send reprint requests to: Prof. Orazio Cantoni, Istituto di Farmacologia e Farmacognosia, Università di Urbino, Via S. Chiara, 27, 61029 Urbino (PS), Italy.
- Abbreviations:
- tB-OOH
- tert-butylhydroperoxide
- BSO
- L-buthionine-[S, R]-sulphoximine
- β-OHB
- β-hydroxybutyrate
- NPSH
- non-protein sulphydryl
- GPx
- glutathione peroxidase
- GSH
- reduced glutathione
- NADH
- nicotinamide adenine dinucleotide reduced form
- Received July 2, 1997.
- Accepted November 21, 1997.
- The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|